Skip to main content
OpenTrials
Completed

NCT Number: NCT00198822

Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh

The purpose of this trial is to determine whether providing women with a weekly oral supplement of vitamin A, either preformed or as beta-carotene, at a dosage equivalent to a recommended intake from early pregnancy through three months postpartum, can reduce the risk of maternal mortality, fetal loss, or infant mortality.

Completed

Looking for future studies?

Notify Me

Key information

Age range

15 year–49 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 3

Primary location

JiVitA Bangladesh Project, Rangpur, Rajshahi Division, Bangladesh

Loading trial locations.

About this study

Maternal mortality and vitamin A deficiency coexist in rural South Asia. In Nepal, weekly supplementation with vitamin A or beta-carotene during the child-bearing years reduced all-cause maternal mortality and, in night blind women, also infant mortality. The present trial is testing the efficacy of the same supplements from ~9 weeks' gestation to 12 weeks postpartum. The planned sample size is 68,000 pregnancies. It is being conducted in 19 rural unions, covering an area of ~750 sq km with a population of ~580,000 in Gaibandha and Southern Rangpur Districts in Northern Bangladesh. The study area was mapped as 596 "sectors" (unit of randomization), each comprising 200-275 households; ~135,000 houses were numerically addressed and, at the outset, 103,000 women were listed. Women are visited at home every 5 weeks by 596 trained female staff to detect pregnancy by a combination of menstrual history and urine testing. Newly married women are prospectively enlisted for pregnancy surveillance. Following informed consent urine-positive (pregnant) women detected during surveillance are enrolled to receive weekly a capsule containing 7000 retinol equivalents of preformed vitamin A, 42 mg of beta-carotene or placebo. Vital events are recorded weekly through 3 months postpartum. Trained interviewers conduct maternal nutritional and health and household socioeconomic assessments in the 1st trimester. At 3 months postpartum, interviewers assess both mother and infant for health and nutritional status, including apparent birth defects that are later physician-confirmed. An additional home health assessment occurs at 6 months post partum, and vital status is recorded for mother and infant at one year postpartum. A ~3% subsample of enrolled pregnant women participate in a substudy involving enhanced clinical, anthropometric, biochemical, body compositional, morbidity and interview-based assessment protocols in the 1st, 2nd and 3rd trimesters, and at 3 months post-partum. Reported maternal and infant deaths are verified and causes ascertained during "verbal autopsy" interviews with family members of the deceased.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Married women of reproductive age
  • First pregnancy during time period of trial

Exclusion criteria

  • Premenarchial girls
  • Married women with a previous pregnancy enrolled into the trial
  • Previously married women who have moved into the study area
  • Single women (never married, widowers)
  • Women who are sterilized (or whose husbands are sterilized)
  • Menopausal women

Treatment and study plan

Vitamin A or Beta-Carotene Supplements

Dietary Supplement

weekly dosage of either 7000 µg retinol equivalents as preformed vitamin A or 42 mg of beta-carotene from 1st trimester of pregnancy through 12 weeks after termination of pregnancy

Primary outcomes

  1. All-cause, Pregnancy-related Mortality

    Time frame: Deaths during pregnancy through 12 weeks postpartum

    Mortality evaluated on intent-to-treat basis

Secondary outcomes

  1. All-cause 3-month Infant Mortality

    Time frame: Deaths through the 1st 12 weeks of life

  2. Maternal Morbidity, Including Obstetric Complications

    Time frame: through the 1st 24 weeks following termination of pregnancy

  3. Gestational Age at Birth

    Time frame: within 24 weeks after birth

  4. Fetal Growth and Postnatal Infant Growth Through Three Months of Age

    Time frame: through the 1st 12 weeks after birth

  5. Infant Morbidity Through 3 Months of Age

    Time frame: within 24 weeks after birth

  6. Plasma Beta-carotene in the Third Trimester of Pregnancy(Nutritonal Status of the Mother)

    Time frame: Third trimester of pregnancy (about the 32nd week of gesatation)

  7. Plasma Retinol at the Third Trimester of Pregnancy (Nutritional Status of the Mother)

    Time frame: Third trimester of pregnancy (about the 32nd week of gestation)

Sponsors and collaborators

Lead sponsor

Johns Hopkins Bloomberg School of Public Health

Other

Collaborators

  • Access Business Group
  • Bill and Melinda Gates Foundation
  • Canadian International Development Agency
  • The Sight and Life Research Institute
  • United States Agency for International Development (USAID)

Registry information

Important dates

Study start
2001
Primary completion
2007
Study completion
2008
First posted
Sep 20, 2005
Registry last updated
Mar 7, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.